1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians 2021, 71(3):209-249.
2. Song Z, Wu Y, Yang J, Yang D, Fang X: Progress in the treatment of advanced gastric cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017, 39(7):1010428317714626.
3. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F: Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014, 23(5):700-713.
4. Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M: Noncoding RNAs in gastric cancer: implications for drug resistance. Molecular cancer 2020, 19(1):62.
5. Zhang G, Li S, Lu J, Ge Y, Wang Q, Ma G, Zhao Q, Wu D, Gong W, Du M et al: LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Molecular cancer 2018, 17(1):87.
6. Feng H, Liu X: Interaction between ACOT7 and LncRNA NMRAL2P via Methylation Regulates Gastric Cancer Progression. Yonsei medical journal 2020, 61(6):471-481.
7. Deng W, Zhang Y, Cai J, Zhang J, Liu X, Yin J, Bai Z, Yao H, Zhang Z: LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling. Experimental biology and medicine (Maywood, NJ) 2019, 244(12):953-959.
8. Hatakeyama S: TRIM proteins and cancer. Nature reviews Cancer 2011, 11(11):792-804.
9. Xu M, Hu J, Zhou B, Zhong Y, Lin N, Xu R: TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/β-catenin signaling pathway. Acta biochimica et biophysica Sinica 2019, 51(1):68-77.
10. Xu W, Chen B, Ke D, Chen X: TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin. Aging 2020, 12(13):13488-13501.
11. Wang C, Zhou Y, Chen B, Yuan W, Huang J: Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection. Oncology letters 2018, 15(4):5792-5798.
12. Qiu F, Xiong JP, Deng J, Xiang XJ: TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185. International journal of clinical and experimental pathology 2015, 8(5):5053-5061.
13. Sobierajska K, Ciszewski WM, Macierzynska-Piotrowska E, Klopocka W, Przygodzka P, Karakula M, Pestka K, Wawro ME, Niewiarowska J: The New Model of Snail Expression Regulation: The Role of MRTFs in Fast and Slow Endothelial-Mesenchymal Transition. International journal of molecular sciences 2020, 21(16).
14. Bhan A, Soleimani M, Mandal SS: Long Noncoding RNA and Cancer: A New Paradigm. Cancer research 2017, 77(15):3965-3981.
15. Huang Y, Zhang J, Hou L, Wang G, Liu H, Zhang R, Chen X, Zhu J: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. Journal of experimental & clinical cancer research : CR 2017, 36(1):194.
16. Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, Xu W, Jiang T, Feng L, Shin VY et al: Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell death & disease 2019, 10(6):383.
17. Zhang C, Lian H, Xie L, Yin N, Cui Y: LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Biological chemistry 2020, 401(9):1053-1061.
18. Lei R, Feng L, Hong D: ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis. Cancer biomarkers : section A of Disease markers 2020, 27(4):433-443.
19. Jie Y, Ye L, Chen H, Yu X, Cai L, He W, Fu Y: ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer. Bioengineered 2020, 11(1):872-882.
20. Dong L, Ding C, Zheng T, Pu Y, Liu J, Zhang W, Xue F, Kang P, Ma Y, Wang X et al: Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration. American journal of translational research 2019, 11(11):6989-6999.
21. Ma XR, Xu YL, Qian J, Wang Y: Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p. European review for medical and pharmacological sciences 2019, 23(4):1536-1544.
22. Kong Q, Qiu M: Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochemical and biophysical research communications 2018, 495(2):1594-1600.
23. Feng R, Li Z, Wang X, Ge G, Jia Y, Wu D, Ji Y, Wang C: Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis. Cancer cell international 2021, 21(1):67.
24. Sun J, Yan J, Qiao HY, Zhao FY, Li C, Jiang JY, Liu BQ, Meng XN, Wang HQ: Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation. Oncogene 2020, 39(3):546-559.
25. Hao L, Wang JM, Liu BQ, Yan J, Li C, Jiang JY, Zhao FY, Qiao HY, Wang HQ: m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells. Biochimica et biophysica acta Molecular cell research 2021, 1868(1):118878.
26. Sun J, Zhang T, Cheng M, Hong L, Zhang C, Xie M, Sun P, Fan R, Wang Z, Wang L et al: TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway. Journal of experimental & clinical cancer research : CR 2019, 38(1):104.